Gastric Neuroendocrine Tumors: Reappraisal of Type in Predicting Outcome.
Andrew N HannaCaroline Kim-KiselakRebecca TangDavid C MetzZhaohai YangRonald DeMatteoDouglas L FrakerRobert E RosesPublished in: Annals of surgical oncology (2021)
Size and tumor grade predict recurrence and survival in patients with GNETs irrespective of type. Small, low-grade type III GNETs are associated with minimal risk of progression and may be managed accordingly.